title: Letter: clarithromycin dose for H. pylori therapy remains unresolved--authors' reply.
authors.affiliation: Division of Gastroenterology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon. ala.sharara@aub.edu.lb.
authors.forename: A I
authors.initials: AI
authors.lastname: Sharara
authors.affiliation: Division of Gastroenterology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
authors.forename: A H
authors.initials: AH
authors.lastname: Harb
authors.affiliation: Division of Gastroenterology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
authors.forename: J M
authors.initials: JM
authors.lastname: Chalhoub
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017291:Clarithromycin / Q000627:therapeutic use*; D016481:Helicobacter Infections / Q000188:drug therapy*; D006801:Humans
chemical_list: D000900:Anti-Bacterial Agents; D017291:Clarithromycin